Clinical Trials Browser

Phase 3 × INDUSTRY × Aprotinin × Clear all

NCT00306150 2014-12-17

Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

Phase 3 Terminated

Blood Loss, Surgical, Postoperative Hemorrhage

NCT00306137 2014-12-09

Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer

Phase 3 Terminated

Blood Loss, Surgical